Advances in Biomaterials Modification and Thrombosis Inhibition

With the development of modem medical technology, the clinical range of biomaterial applications have gradually expanded.However, bioactivity on the surface of biomaterials may be reduced and induce thrombus formation that will not only cause serious dysfunction of the biological materials, but can also affect the host.Modification of these biological materials can thus help to retain the biological activity on the surface of the material and inhibit thrombus formation, which underlines the importance of their clinical application.The current review will address the modification of biomaterials and inhibition of thrombosis on the surface of biomaterials.
Thrombus biomaterials modification
Shidong Hu Binen Nie Jianliang Zhou
Department of Cardiothoracic Surgery, The Second Affiliated Hospital, Nan Chang University, Nanchang 330006, Jiangxi Province P.R.China
国际会议
The Eighth China National Conference on Functional Materials and Applications(第八届中国功能材料及其应用学术会议)
哈尔滨
英文
635-641
2013-08-23(万方平台首次上网日期,不代表论文的发表时间)